HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Jessica Mann Selected Research

inclacumab

11/2016Effects of the P-Selectin Antagonist Inclacumab on Myocardial Damage After Percutaneous Coronary Intervention According to Timing of Infusion: Insights From the SELECT-ACS Trial.
5/2013Effects of the P-selectin antagonist inclacumab on myocardial damage after percutaneous coronary intervention for non-ST-segment elevation myocardial infarction: results of the SELECT-ACS trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Jessica Mann Research Topics

Disease

2ST Elevation Myocardial Infarction
11/2016 - 05/2013
1Arteritis
02/2016
1Non-ST Elevated Myocardial Infarction
05/2013
1Proteinuria
09/2009
1Thrombosis (Thrombus)
09/2009
1Atherosclerosis
09/2009
1Heart Failure
11/2007
1Tuberculosis (Tuberculoses)
04/2003
1Essential Hypertension
01/2002
1Hypertension (High Blood Pressure)
01/2002

Drug/Important Bio-Agent (IBA)

2inclacumabIBA
11/2016 - 05/2013
2P-SelectinIBA
11/2016 - 05/2013
1Monoclonal AntibodiesIBA
11/2016
1Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link
02/2016
1Thromboxane A2 (A2, Thromboxane)IBA
09/2009
1Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA
09/2009
1Renin InhibitorsIBA
11/2007
1aliskirenFDA Link
11/2007
1NitrogenIBA
04/2003
1Amlodipine (Norvasc)FDA LinkGeneric
01/2002
1Valsartan (Vals)FDA Link
01/2002
1Hydrochlorothiazide (Esidrix)FDA LinkGeneric
01/2002

Therapy/Procedure

2Percutaneous Coronary Intervention
11/2016 - 05/2013
1Stents
09/2009